…and some to hold, avoid or sell

Aggreko Sharecast

The temporary power provider faces a slowdown in order intake, intensified competition and FX headwinds. Berenberg expects US cyclical recovery to be temporary and offset by disappointment elsewhere. Target 770p. Sell. 886p.

Convatec Group Investors Chronicle

This maker of colostomy bags and medical devices is weighed down by debt. Costs are rising, growth is disappointing, and currency swings threaten margins. Private equity owners are reducing stakes. Sell. 268.5p.

DX Group Investors Chronicle

The parcel delivery firm’s shares have “performed dismally” since coming to the market at 100p, and there’s no sign of an upswing. DX is struggling with a substantial debt pile and profits are down 78%. Sell. 7.2p.

Foxtons Group Investors Chronicle

The London-focused estate agent has been hit by fears over house prices, changes to stamp duty and tighter mortgage lending. Shares are 70% below their 2013 listing price, sales have fallen 29% and profits by 64%. Sell. 68p.

The Mail on Sunday

Analysts are divided over prospects for the troubled education publisher. Exane BNP Paribas argues that Q3 results may be positive. But Liberum has repeated its “sell note”. Sell. 612p.

Royal Bank of Scotland Sharecast

Although management’s credibility is “sky-high” following strong results, Investec expects £150m of equity issuance and a £1.8bn loss in the second half. The broker thinks RBS “no longer looks cheap enough”. Sell. 264.9p.